| Quarter | Score |
|---|---|
| 2014-Q2 | 49.1 |
| 2014-Q3 | 48.8 |
| 2018-Q1 | 47.9 |
| 2018-Q2 | 61.6 |
| 2018-Q3 | 51.0 |
| 2019-Q2 | 49.9 |
Funds reducing exposure or consensus momentum fading
No price reference available to measure drift vs fund cost basis
0 of 16 tracked funds hold DRNA. Net holding.
Current price unavailable — check back later
No current holders
New to consensus — no prior quarter to compare
Too early to measure — check back next quarter
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 16 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|